Richard Kempson

Publication Details

• Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.

  Archer DF, Thorneycroft IH, Foegh M, Hanes V, Glant MD, Bitterman P, Kempson RL. Menopause. 2005 Nov-Dec; 12 (6): 716-27

  The purpose of this multicenter, double-blind, randomized, parallel-group study was to determine the effect of thirteen 28-day cycles of drospirenone combined with estradiol, compared with estradiol alone, on the endometrium of postmenopausal women.

  PubMedID: 16278615